1 Min Read
* CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
* AS OF DECEMBER 31, 2017, CASI HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $43.5 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.